Climb Bio stock surges 17% on positive drug trial results

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 3 hours ago

Soitec surges as JPMorgan upgrades stock, doubles price target on photonics boom

Investing.com

stocksabout 3 hours ago

FTSE 100 today: Stocks edge higher as miners rally; Beijing presses U.S.-Iran talk

Investing.com

stocksabout 3 hours ago

Why is Babcock International stock climbing today?

Investing.com